Medical Properties Trust, Inc. (NYSE:MPT - Get Free Report) shares reached a new 52-week low on Thursday. The company traded as low as $1.70 and last traded at $1.71, with a volume of 3,408,668 shares. The stock had previously closed at $1.78.
Wall Street Analysts Forecast Growth
Several equities research analysts have issued reports on the stock. BNP Paribas Exane lowered shares of Medical Properties Trust from an "outperform" rating to a "neutral" rating and set a $2.25 price target on the stock. in a report on Tuesday, November 3rd. Weiss Ratings raised shares of Medical Properties Trust from a "sell (d)" rating to a "sell (d+)" rating in a report on Monday. Wells Fargo & Company decreased their target price on shares of Medical Properties Trust from $5.00 to $3.80 and set an "underweight" rating on the stock in a research report on Tuesday, September 1st. Finally, Royal Bank Of Canada cut shares of Medical Properties Trust from a "sector perform" rating to an "underperform" rating and lowered their target price for the company from $4.50 to $2.00 in a research note on Friday, October 30th. One analyst has rated the stock with a Hold rating and three have assigned a Sell rating to the company's stock. According to MarketBeat, Medical Properties Trust has an average rating of "Strong Sell" and a consensus target price of $2.68.
View Our Latest Analysis on MPT
Medical Properties Trust Trading Down 4.5%
The firm has a market cap of $1.00 billion, a P/E ratio of 4.15 and a beta of 1.50. The company has a current ratio of 3.92, a quick ratio of 3.12 and a debt-to-equity ratio of 2.00. The company's fifty day moving average price is $3.07 and its two-hundred day moving average price is $4.24.
Medical Properties Trust (NYSE:MPT - Get Free Report) last announced its quarterly earnings results on Thursday, October 29th. The company reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.13 by ($0.02). The firm had revenue of $250.14 million for the quarter. Medical Properties Trust had a net margin of 24.14% and a return on equity of 5.45%. The firm's quarterly revenue was up 5.3% compared to the same quarter last year. As a group, sell-side analysts predict that Medical Properties Trust, Inc. will post 0.51 EPS for the current fiscal year.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently modified their holdings of MPT. BlackRock Inc. bought a new position in Medical Properties Trust in the 2nd quarter worth approximately $347,673,000. Corient Private Wealth LP acquired a new position in Medical Properties Trust during the 2nd quarter worth $3,670,000. Allianz Asset Management GmbH acquired a new position in Medical Properties Trust during the 2nd quarter worth $33,903,000. State Street Corp bought a new position in Medical Properties Trust in the 2nd quarter valued at $118,522,000. Finally, Envestnet Asset Management Inc. bought a new position in Medical Properties Trust in the 2nd quarter valued at $1,596,000. 71.79% of the stock is owned by institutional investors and hedge funds.
About Medical Properties Trust
(
Get Free Report)
Medical Properties Trust is a real estate investment trust that owns and invests in healthcare facilities, with a primary focus on hospitals. The company leases its properties to healthcare operators and may provide financing related to the acquisition or development of medical facilities. Founded in 2003, Medical Properties Trust has built a portfolio of properties serving acute-care, behavioral health, rehabilitation and other healthcare needs. Its investments have included facilities in the United States and international markets.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Medical Properties Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medical Properties Trust wasn't on the list.
While Medical Properties Trust currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.